APART Advanced Profiling of Anti-Rheumatic Therapies
A Multicenter, Randomized, Open Study to Evaluate the Impact of an Electronic Data Capture System on the Care of Patients With Rheumatoid Arthritis
1 other identifier
interventional
1,079
0 countries
N/A
Brief Summary
The purpose of this study is to evaluate the utility of an electronic data capture system (EDCS) in a rheumatology clinical practice setting and to assess the impact of this system on patient satisfaction with patient-physician interaction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_4
Started Jan 2004
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2004
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2005
CompletedFirst Submitted
Initial submission to the registry
September 15, 2006
CompletedFirst Posted
Study publicly available on registry
September 19, 2006
CompletedMay 19, 2011
April 1, 2010
September 15, 2006
May 18, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Primary endpoints for the Health Tracker-user group are the change in the patient satisfaction and patient-physician interaction surveys between the pre- and post-randomization phases.
Secondary Outcomes (1)
Changes between the pre- and post-randomization phases in the following clinical evaluations: HAQ scores, SF-12 scores, Patient assessed painful and/or swollen joint counts, Health care professional assessed tender and swollen joint counts
Interventions
Eligibility Criteria
You may qualify if:
- Patients diagnosed with active rheumatoid arthritis according to the revised criteria of the ACR (1987)
- Have rheumatoid arthritis that requires regularly scheduled visits with their rheumatologist at least every 3 months
- Willing and able to adhere to protocol requirements and participate in a study, lasting 12 months
You may not qualify if:
- Patients currently receiving investigational drugs
- Currently participating in other clinical trials or safety registries for rheumatoid arthritis or rheumatoid arthritis -related therapies
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Centocor, Inc. Clinical Trial
Centocor, Inc.
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
September 15, 2006
First Posted
September 19, 2006
Study Start
January 1, 2004
Study Completion
July 1, 2005
Last Updated
May 19, 2011
Record last verified: 2010-04